1-3 of 3
Stéphanie Dulucq
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy

Gabriel Etienne, MD, PHD, Nicolini E Nicolini, MD, PhD, Stéphanie Dulucq, Anna Schmitt, Sandrine Hayette, Éric Lippert, MD, PhD, Isabelle Tigaud, MD, Stephane Morisset, Stat., Caroline Bureau, Didier Adiko, Gerald Marit, MD, Josy Reiffers, MD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3754.
https://doi.org/10.1182/blood.V120.21.3754.3754
Published: 2012
Journal Articles

A More Sensitive RQ-PCR to Assess Complete Molecular Remission Does Not Allow the Prediction of Relapse After Discontinuation of Imatinib In Chronic Myeloid Leukemia.

Francois-Xavier Mahon, MD, PhD, Stéphanie Dulucq, Francois Guilhot, Laurence Legros, MD, Philippe Rousselot, MD, PhD, Coralie Belanger, Gabriel Etienne, Josy Reiffers, Delphine Rea, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2298.
https://doi.org/10.1182/blood.V116.21.2298.2298
Published: 2010
Journal Articles

Paroxysmal Nocturnal Hemoglobinuria and Pregnancy: The French Experience.

Sophie de Guibert, Régis Peffault de Latour, Nathalie Varoqueaux, Hélène Labussiere, Bernard Rio, Dominique Jaulmes, Jean-Richard Eveillard, Stéphanie Dulucq, Anne Marie Stoppa, Didier Bouscary, François Girodon, Bernard Bonnotte, Gérard Socié, Thierry Lamy
Journal: Blood
Blood (2009) 114 (22): 1984.
https://doi.org/10.1182/blood.V114.22.1984.1984
Published: 2009